Tag: Medical Cannabis

In the News: Kicking off 2020 with big wins, including new tender to operate medical cannabis incubator

In the News: Kicking off 2020 with big wins, including new tender to operate medical cannabis incubator

Jan 5, 2020 |

We ended off 2019 with exciting news for OurCrowd and the Israeli ecosystem. Israeli tech raised over $350M in December, and raised a record $8.19B in 2019, easily surpassing the $6.4B raised in 2018, which was itself a record. In OurCrowd’s fifth incubator win, the consortium consisting of OurCrowd, Perrigo and BOL Pharma, won the Israeli government tender to operate CanNegev, a medical cannabis incubator that will be located in Yeruham, in the south of Israel. This will be the world’s first government-supported medical cannabis technology incubator.  As I told NoCamels, in this past decade, the Israeli tech ecosystem came into its own. What was interesting, full of potential and a promising phenomenon, became a powerhouse juggernaut that everybody in the world now has recognized. A decade ago, getting to $1 billion in equity crowdfunded assets was but a dream. I was humbled to be featured as one of 17 Israelis that shaped the decade. Startup Nation and beyond In-depth look at Alpha Tau – Alpha Tau’s Alpha DaRT is the first technology to provide a highly localized and effective...

Read More
All your questions, answered: 8 things to know about the medical cannabis industry [AMA with Dr. Morris Laster]

All your questions, answered: 8 things to know about the medical cannabis industry [AMA with Dr. Morris Laster]

May 20, 2015 | , ,

Medical cannabis is the next frontier of medtech investing, forecasted to become a $35 billion industry by 2020. How are the challenges of this industry being resolved? Your questions, answered: OurCrowd presents our first investor AMA (“ask me anything”) with medtech advisor, Venture Partner and 25-year industry veteran Dr. Morris Laster. Below, Dr. Laster addresses medical cannabis, providing answers and insight into the industry as well as the medtech advances made by Syqe Medical, developers of the world’s first meter-dosed botanical inhaler and OurCrowd’s current investment opportunity. Missed the live AMA? Have more queries about the medical cannabis industry? Don’t let your questions go unanswered!  Leave a comment below and we’ll answer them! —————- About Dr. Laster Dr. Laster is a physician with over 25 years of experience in the biopharmaceutical industry and with expertise in identification, development and management of advanced biomedical drugs and technologies. Dr. Laster is the Venture Partner responsible for Medtech investments at OurCrowd; he has founded and/or managed six companies that have gone public in the US, UK and Israel. He invented a novel device to access the circulatory system through the bone...

Read More